Lexology October 10, 2023
Reed Smith LLP

We can sum up the claim in Telebrands Corp. v. Luminas Int’l LLC, like this—hey court, it’s not fair that I’m following the FDA’s rules and my competitors are not, so you should force them to do so to even the playing field. 2023 U.S. Dist. LEXIS 179285 (S.D. Cal. Jul. 12, 2023). To which the court appropriately said—you’ve come to the wrong place; FDA rules are the FDA’s to enforce. In other words, all your claims are impliedly preempted and so they are dismissed without leave to amend.

Plaintiff is an online seller of over-the-counter analgesic patches used for pain relief. Plaintiff has listed its patches on the FDA’s National Drug Code (“NDC”) database. Id. at *2. Doing so...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies
Who’s Leading the FDA’s AI Race? Top Medical Specialties and Companies to Watch
FDA issues flu vaccine recommendations: 5 respiratory updates
5 Digital Health Areas To Be Impacted By The FDA Layoffs
FDA Approves First Biosimilar to Omalizumab
Trump's Nominees to Run FDA, NIH Get Greenlighted by Senate Committee

Share This Article